For following the competition: what moved in each program, several studies read as one move.
- disitamab vedotin
- RC148
- telitacicept
- + 7 more
Mondays · ranked, phase 3 first · readouts ahead · See a sample brief
Add RemeGen to watchlistEvery Monday by email · turn it off any timePro · free during the beta